You are here
Large-scale study of NSAIDS finds no link to heart attack
IN 2004, when drugmaker Merck voluntarily pulled the pain-reliever Vioxx off the market amid evidence that it increased the risk of heart attacks, concern naturally turned to its nearly identical rival, Celebrex.
The medication works the same way, by inhibiting
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org